Cambridge oncology company Tango Therapeutics has signed a deal with a special-purpose acquisition company sponsored by San Diego’s Boxer Capital, to go public through a reverse merger, combined with a private investment in public equity, or PIPE, from the likes of Avoro Capital and Bain.

Boston Biz Journal https://www.bizjournals.com/boston/news/2021/04/14/spac-attack-tango-therapeutics-to-go-public.html?ana=RSS&s=article_search